PET reimbursement
This article was originally published in The Gray Sheet
Executive Summary
CMS announces Nov. 23 its decision to withdraw Medicare coverage for certain 2-[F-18] fluoro-D-glucose PET scanners. As of Jan. 1, PET imaging must be performed on either FDA-approved full or partial-ring scanners or coincidence systems that have a crystal at least 5/8" thick, techniques to minimize or correct for scatter and or randoms, and digital detectors and iterative reconstruction. The reduction in coverage was originally proposed in a June 29 decision memorandum (1"The Gray Sheet" July 9, 2001, p. 4)...